Health news

  1. New relief for migraine patients?

    News updateThe first-ever preventative treatment for migraine in adults, Aimovig (erenumab-aooe) is now approved by the Food and Drug Administration.

    Read more »
  2. Imfinzi may offer patients benefits in earlier stages of lung cancer

    Industry NewsNew clinical results show that Durvalumab improved survival (versus a placebo) in patients with non–small cell lung cancer.

    Read more »
  3. All about Aimovig (erenumab-aooe): the unique new migraine treatment

    A new preventive migraine treatment, Aimovig (erenumab-aooe), poses promising possibilities for some migraine sufferers.

    Aimovig

    Read more »
  4. New prices negotiated! Reductions for 38 products

    Price decreases for 38 medicines

    Read more »
  5. New microneedle product could help people with ALS, MS and diabetes

    Remember the hypospray from Star Trek? Maybe it's close to reality.

    Star Trek magazine cover

    Read more »
  6. New medicines coming soon!

    A list of medicines TheSocialMedwork will soon be making available.

    New medicines

    Read more »
  7. Promising Developments in Treatment of Multiple Myeloma!

    Darzalex (daratumumab) combination under review as first-line option.

    Multiple Myeloma

    Read more »
  8. Spinraza, the new medicine for spinal muscular atrophy

    Is there substance to the claims that it's a groundbreaking treatment?

    Spinraza

    Read more »
  9. Why is there often a substantial delay in getting access to new medicines – even after they are approved?

    We talk to Sera, our Medicines Sourcing Manager about why drug delays happen...

    Drug delays

    Read more »
  10. A new medicine for Alzheimer's disease?

    Introducing a breakthrough known as 'CT1812'

    alzheimer disease

    Read more »
Posts loader

Just one thing before you continue

Our service contains information about acquiring treatments that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

No, take me out of here.
CONTINUE